Pancreatic Cancer Research

ResearcherAffiliated Hangzhou First People's Hospital, Westlake University, School of MedicineNo recent work listed

Bin Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5385-3176; OpenAlex author ID A5100427348. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
4
Papers, trials and grants by year

2014: 2 papers

Papers 2

  1. Perifosine inhibits S6K1-Gli1 signaling and enhances gemcitabine-induced anti-pancreatic cancer efficiency. Last author DOI 10.1007/s00280-014-2397-9↗
  2. The novel mTORC1/2 dual inhibitor INK-128 suppresses survival and proliferation of primary and transformed human pancreatic cancer cells. Last author DOI 10.1016/j.bbrc.2014.06.081↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ying Xin · 1 shared paper, 2014 · strength 0.06
  2. Defei Hong · 1 shared paper, 2014 · strength 0.06
  3. Long Cheng · 1 shared paper, 2014 · strength 0.06
  4. Haizhou Lou · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.